Olatec Therapeutics
0 followers
Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma,... Read more
Org chart
Damaris B. Skouras
Founder, Chairman & CEO
Damaris B. Skouras
Collapse
Charles A. Dinarello
Chairman, SAB & co-Chief Scientific Officer
Joseph St. Laurent
Co-Chief Scientific Officer
Mustafa Noor
Chief Medical Officer
Cynthia (Dana) Barrow
VP Compliance And Risk
Jeanette Rooney, CPA, CGMA
Vice President Finance & Treasurer
Piscitelli Philip
Vice President, Clinical Development Operations
